Clinical utility of a 1.5 T magnetic resonance imaging-guided linear accelerator during conventionally fractionated and hypofractionated prostate cancer radiotherapy

Clinical utility of a 1.5 T magnetic resonance imaging-guided linear accelerator during conventionally fractionated and hypofractionated prostate cancer radiotherapy

PurposeTo report our initial experience with 1.5 T magnetic resonance imaging (MRI) linear accelerator (LINAC) in prostate cancer radiotherapy in terms of its use in a radiation oncology clinic.MethodsThe medical records of 14 prostate cancer patients treated with MRI-guided radiotherapy were retros...

Full description

Bibliographic Details
Main Authors: Gorkem Turkkan, Nazli Bilici, Huseyin Sertel, Yavuz Keskus, Sercan Alkaya, Busra Tavli, Muge Ozkirim, Merdan Fayda
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
adaptive radiotherapy
fractionated radiotherapy
MRI-guided radiotherapy
MRI-LINAC
prostate cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.909402/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.909402/full

Similar Items